PRECISE, a two arm, double blind randomised controlled trial of pregabalin in addition to usual care compared to placebo with usual care for reducing leg pain in patients with sciatica.

Trial Profile

PRECISE, a two arm, double blind randomised controlled trial of pregabalin in addition to usual care compared to placebo with usual care for reducing leg pain in patients with sciatica.

Completed
Phase of Trial: Phase IV

Latest Information Update: 18 Jul 2017

At a glance

  • Drugs Pregabalin (Primary)
  • Indications Pain; Sciatica
  • Focus Therapeutic Use
  • Acronyms PRECISE
  • Most Recent Events

    • 18 Jul 2017 Results published in the Annals of Internal Medicine
    • 31 Mar 2017 Status changed from active, no longer recruiting to completed.
    • 23 Mar 2017 Primary endpoint (Average leg pain intensity over the last 24 hours measured by the numeral pain rating scale) has not been met, according to the results published in the New England Journal of Medicine
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top